We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Methods Compared for Detection of Fecal Giardiasis

By LabMedica International staff writers
Posted on 27 Mar 2016
Microscopy for intestinal protozoa after formol-ether (FE) or formol-ethylacetate (FEA) concentration is standard procedure for investigating patients with diarrhea where a protozoan etiology is suspected. More...


In recent times, polymerase chain reaction (PCR) or fluorescence-labeled parasite-specific antibodies have been introduced for infections with intestinal protozoan parasites like Giardia duodenalis (syn. G. intestinalis and G. lamblia), Cryptosporidium but their place in everyday routine diagnostics has not yet been established.

Scientists at Aarhus University Hospital (Denmark) compared FEA and salt–sugar flotation (SSF) concentration followed by microscopy of iodine-stained concentrate and immunofluorescence assay (IFA) and real-time polymerase chain reaction (qPCR) for detection of Giardia duodenalis in human feces. Consecutive 455 fecal samples received between August 2012 and April 2013 at the hospital were included. FEA was performed within 48 hours after receipt of the samples. The samples were kept at + 4 °C for up to 90 days prior to qPCR analysis.

Immunofluorescence assays were performed on diluted feces after proper mixing, and a direct smear was made on Teflon coated slides containing three wells of 10 mm (Menzel Gläser, Braunschweig, Germany). The smears were left to air dry at room temperature overnight stained with FITC-labeled anti-Giardia antibodies (Cellabs; Brookvale Australia). Real-time polymerase chain reactions (qPCR) were performed where the crossing point-PCR-cycle (Cp) is the value given by the LightCycler 480 (Roche Diagnostics; Mannheim, Germany) and is similar to cycle threshold (Ct). It is the cycle at which fluorescence achieves a defined threshold.

The median number of Giardia cysts found by FEA in 19 Giardia-positive samples was 50 cysts per gram (CPG), by SSF 350 CPG, by IFA 76,700 CPG, and by qPCR 316,000 CPG. The team next tested 455 consecutive samples for presence of Giardia cysts. Using IFA as reference, qPCR had a sensitivity of 91%, specificity of 95.1%, a false-positive rate of 50%, a false-negative rate of 0.48%, a positive predictive value of 50%, and a negative predictive value of 99.5%.

The authors concluded that qPCR and IFA were significantly more sensitive than microscopy of iodine-stained concentrates using either FEA or SSF. They suggest, when using qPCR, that positive samples are verified by IFA to prevent false-positive results. The study was published in the March 2016 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Aarhus University Hospital
Menzel Gläser 
Cellabs 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Immunofluorescence Analyzer
IFA System
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image:Geographic distribution of the survey respondents. (Cavalier E, Kapoula G, Bhattoa HP, et al. IOF-IFCC international survey of global laboratory practices for bone status indices. Clin Chem Lab Med. 2026. DOI:10.1515/cclm-2026-0941.)

Global Laboratory Survey Underscores Need to Standardize Bone Biomarker Testing

Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. For more than 20 years, standardization... Read more

Molecular Diagnostics

view channel
Image: Developed and manufactured by Freenome and exclusively commercialized by Abbott, SimpleScreen CRC joins the Cologuard Plus test in Abbott’s screening portfolio, which now spans both stool‑ and blood‑based options (Photo courtesy of Freenome)

Blood-Based Test Broadens Colorectal Cancer Screening Options

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., yet outcomes improve markedly when the disease is detected through routine screening. Despite this, up to 60 million Americans... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.